{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:07:05Z","timestamp":1786990025019,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","award":["2019-01-07-00-07-E00046"],"award-info":[{"award-number":["2019-01-07-00-07-E00046"]}],"id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic Research Leader","doi-asserted-by":"publisher","award":["20XD1403300"],"award-info":[{"award-number":["20XD1403300"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2023YFC2508106"],"award-info":[{"award-number":["2023YFC2508106"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003334"],"award-info":[{"award-number":["82003334"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003335"],"award-info":[{"award-number":["82003335"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073429"],"award-info":[{"award-number":["82073429"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203908"],"award-info":[{"award-number":["82203908"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273510"],"award-info":[{"award-number":["82273510"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.heliyon.2024.e24096","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T20:43:12Z","timestamp":1704746592000},"page":"e24096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Decreased risk of COVID-19 and long COVID in patients with psoriasis receiving IL-23 inhibitor: A cross-sectional cohort study from China"],"prefix":"10.1016","volume":"10","author":[{"given":"Yifan","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfeng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.heliyon.2024.e24096_bib1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1684\/ejd.2012.1802","article-title":"Prevalence of psoriasis in China: a population-based study in six cities","volume":"22","author":"Ding","year":"2012","journal-title":"Eur. J. Dermatol."},{"issue":"10281","key":"10.1016\/j.heliyon.2024.e24096_bib2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"19","key":"10.1016\/j.heliyon.2024.e24096_bib3","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical Presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e24096_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13509","article-title":"Dermatological diseases presented before COVID-19: are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?","volume":"33","author":"Kutlu","year":"2020","journal-title":"Dermatol. Ther."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e24096_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14050","article-title":"Skin cancer and COVID-19","volume":"33","author":"Goldust","year":"2020","journal-title":"Dermatol. Ther."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e24096_bib6","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jaad.2022.01.048","article-title":"Association of psoriasis with risk of COVID-19: a 2-sample Mendelian randomization study","volume":"87","author":"Gu","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24096_bib7","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2022.2161297","article-title":"Prevalence, risk and severity of SARS-CoV-2 infections in psoriasis patients receiving conventional systemic, biologic or topical treatment during the COVID-19 pandemic: a cross-sectional cohort study (PsoCOVID)","volume":"34","author":"Kwee","year":"2023","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.heliyon.2024.e24096_bib8","article-title":"Risk of COVID-19 infection, hospitalization and mortality in psoriasis patients treated with interleukin-17 inhibitors: a systematic review and meta-analysis","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e24096_bib9","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.jaad.2022.07.040","article-title":"The risk of COVID-19 in patients with psoriasis: a retrospective cohort study","volume":"87","author":"Wu","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e24096_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s40257-021-00603-w","article-title":"Biologic treatment Algorithms for moderate-to-severe psoriasis with comorbid conditions and special populations: a review","volume":"22","author":"Thatiparthi","year":"2021","journal-title":"Am. J. Clin. Dermatol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e24096_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15003","article-title":"Tumor necrosis factor inhibitors are associated with a decreased risk of COVID-19-associated hospitalization in patients with psoriasis-A population-based cohort study","volume":"34","author":"Kridin","year":"2021","journal-title":"Dermatol. Ther."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e24096_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13537","article-title":"COVID-19 re-infection","volume":"51","author":"Brouqui","year":"2021","journal-title":"Eur. J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24096_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s41256-022-00245-3","article-title":"Reinfection in patients with COVID-19: a systematic review","volume":"7","author":"Ren","year":"2022","journal-title":"Glob Health Res Policy"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24096_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jmv.27281","article-title":"Epidemiologic characteristics of cases with reinfection, recurrence, and hospital readmission due to COVID-19: a systematic review and meta-analysis","volume":"94","author":"Sotoodeh Ghorbani","year":"2022","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24096_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10096-020-04088-z","article-title":"Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review","volume":"40","author":"Dao","year":"2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"S7","key":"10.1016\/j.heliyon.2024.e24096_bib16","article-title":"Allergy and COVID-19","volume":"92","author":"De Filippo","year":"2021","journal-title":"Acta Biomed."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24096_bib17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jaip.2021.10.049","article-title":"Impact of allergic rhinitis and asthma on COVID-19 infection, hospitalization, and mortality","volume":"10","author":"Ren","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"162","key":"10.1016\/j.heliyon.2024.e24096_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0152-2021","article-title":"Asthma and COVID-19: an update","volume":"30","author":"Adir","year":"2021","journal-title":"Eur. Respir. Rev."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e24096_bib19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jaip.2020.11.054","article-title":"Prevalence of comorbid asthma and related outcomes in COVID-19: a systematic review and meta-analysis","volume":"9","author":"Liu","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e24096_bib20","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2020.08.008","article-title":"Allergic disorders and susceptibility to and severity of COVID-19: a nationwide cohort study","volume":"146","author":"Yang","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e24096_bib21","doi-asserted-by":"crossref","first-page":"e724","DOI":"10.1016\/S2665-9913(21)00247-2","article-title":"COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses","volume":"3","author":"Fagni","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e24096_bib22","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.29639","article-title":"Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID-19","volume":"4","author":"Izadi","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24096_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaci.2020.10.007","article-title":"Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study","volume":"147","author":"Mahil","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e24096_bib24","doi-asserted-by":"crossref","first-page":"e490","DOI":"10.1016\/S2665-9913(22)00098-4","article-title":"Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform","volume":"4","author":"MacKenna","year":"2022","journal-title":"Lancet Rheumatol"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e24096_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13893","article-title":"COVID-19 infection on IL-23 inhibition","volume":"33","author":"Wang","year":"2020","journal-title":"Dermatol. Ther."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024001270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024001270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:28:22Z","timestamp":1783931302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024001270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2405844024001270"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24096","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased risk of COVID-19 and long COVID in patients with psoriasis receiving IL-23 inhibitor: A cross-sectional cohort study from China","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e24096"}}